Icon Close

Seagen is now part of Pfizer!  Please visit Pfizer.com for more information.

For US residents only.

For healthcare professionals

Arrow down icon

Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference.

In it
to advance cancer care
In it
to advance cancer care

Our industry-leading medicines are approved for the treatment of certain types of Hodgkin lymphoma, urothelial cancer, and breast cancer.

Our Medicines
In it
for new possibilities
In it
for new possibilities

We partner with healthcare professionals and academic institutions to investigate promising new therapies through clinical trials.

Our Clinical Trials
In it
for discovery
In it
for discovery

Our pipeline is designed with patients in mind, focusing on therapies that have the potential to address significant unmet medical needs.

Our Pipeline

Medical information and safety

Request additional information about our medicines, or report an adverse event or product complaint.

Contact Medical Information

Clinical data requests

We support transparency of our data from completed clinical trials or for our commercially available products.

Submit a Request

Investigator-sponsored research

Request support for clinical research that advances medical or scientific knowledge about Seagen’s products or clinical candidates.

Apply for Support

Medical education grants

Learn about our grants for medical education programs that promote clinical excellence and better health outcomes.

Apply for a Grant

Sign up for updates

Receive the latest news about Seagen’s innovations in cancer care.

Sign Up